AK5 suppresses breast cancer progression and modulates anti-PD-L1 efficacy via the miR-182-5p/PD-L1 axis.

iScience · 2026 · PMC13018875 · PMID 41907408

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While correlations with PD-1, PD-L1, and IL-10 trended negative, they did not reach statistical significance, suggesting a broader link between AK5 downregulation and an immunosuppressive TME.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.